LACEY CONAWAY: Open Payments
NPI 1629227608 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 85 payments from 17 companies in 2025. Trend: 2023 $1,502 · 2024 $2,035 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $452 |
| ABBVIE INC. | 15 | $225 |
| Novo Nordisk Inc | 8 | $150 |
| Corcept Therapeutics | 6 | $146 |
| Abbott Laboratories | 3 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| Lilly USA, LLC | 5 | $76 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
Products named: FARXIGA, AIRSUPRA, Korlym, FREESTYLE LIBRE 3, Ozempic, JARDIANCE, LINZESS, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
